Table of Contents
Auris Medical Holding Ltd. (NASDAQ: EARS) rose 91.8% to $1.62 in pre-market trading. Bloomberg reported that Johnson & Johnson was accused in a lawsuit of deceiving investors regarding performance-based earnings from Auris Health. It should be noted the two companies, Auris Medical and Auris Health, are not related. Apex Global Brands Inc. (NASDAQ: APEX) rose 49% to $10.00 in pre-market trading after gaining 15% on Monday. Nxt-ID, Inc. (NASDAQ: NXTD) shares rose 46.6% to $0.4880 in pre-market trading. Altimmune, Inc. (NASDAQ: ALT) shares rose 19.8% to $15.10 in pre-market trading. Altimmune yesterday published positive pre-clinical data on its new COVID-19 vaccine candidate. Color Star Technology Co., Ltd. (NASDAQ: CSCW) rose 16% to $0.6260 in pre-market trading after gaining over 11% on Monday. Ethan Allen Interiors Inc. (NYSE: ETH) shares rose 12% to $17.51 in pre-market trading after the company issued strong Q1 guidance. SM Energy Company (NYSE: SM) rose 9.4% to $1.87 in pre-market trading. The RealReal, Inc. (NASDAQ: REAL) rose 7.5% to $16.51 in pre-market trading. The RealReal, last week, partnered with Gucci to launch online shop featuring pre-loved Gucci Items and promote circularity for luxury fashion. Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 7.3% to $4.98 in pre-market trading. Medigen’s COVID-19 vaccine combined with Dynavax’s CpG 1018 adjuvant received Taiwan government subsidy with first participant dosed in early October. Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 7.1% to $1.06 in pre-market trading. Blue Hat Interactive Entertainment Technology, last week, reported that its joint venture company, Fujian Youth Hand In Hand Educational Technology, reached a 3-year deal with Guangzhou Tongsheng Education Technology in Guangzhou. Yunhong CTI Ltd. (NASDAQ: CTIB) rose 6.5% to $2.12 in pre-market trading after climbing over 22% on Monday. Enlivex Therapeutics Ltd. (NASDAQ: ENLV) rose 6.3% to $12.01 in pre-market trading following a 4% decline on Monday. Enlivex Therapeutics recently issued positive news related to the company’s COVID-19 treatment. Inventiva S.A. (NASDAQ: IVA) rose 6.2% to $14.50 in pre-market trading after the company received FDA Breakthrough Therapy Designation for NASH drug candidate Lanifibranor. Centennial Resource Development, Inc. (NASDAQ: CDEV) rose 5.5% to $0.69 in pre-market trading after declining over 4% on Monday. GoPro, Inc. (NASDAQ: GPRO) rose 4.5% to $7.10 in pre-market trading after gaining around 10% on Monday. GoPro recently issued better-than-expected subscription numbers. The Walt Disney Company (NYSE: DIS) shares rose 4.3% to $130.30 in pre-market trading after the company disclosed a strategic reorganization of its media and entertainment businesses that points to a renewed focus on the direct to consumer streaming model. The company’s CEO Chapek said theme parks are operating at a 25% capacity. ADiTx Therapeutics, Inc. (NASDAQ: ADTX) rose 4.2% to $2.00 in pre-market trading. ADiTx Therapeutics recently reported the launch of AditxtEngage™, a continuing series of investor opportunities to engage with Aditxt. Selecta Biosciences, Inc. (NASDAQ: SELB) rose 4% to $2.12 in pre-market trading after the director, Timothy Springer, purchased 3.18 million shares of the company’s stock at $1.71 per share.
Find out what’s going on in today’s market and bring any questions you have to Benzinga’s PreMarket Prep.
Check out these big penny stock gainers and losers
Wah Fu Education Group Limited (NASDAQ: WAFU) fell 21.5% to $5.39 in pre-market trading after jumping more than 112% on Monday. Hudson Capital Inc. (NASDAQ: HUSN) fell 15.8% to $0.4960 in pre-market trading after jumping over 35% on Monday. Medley Management Inc. (NYSE: MDLY) shares fell 14% to $0.9460 in pre-market trading. Medley Management shares surged around 85% on Monday as the company announced the sale of the MCC Senior Loan Strategy JV portfolio to fund managed by Golub Capital LLC. Performance Shipping Inc. (NASDAQ: PSHG) shares fell 11.7% to $0.5680 in pre-market trading. Performance Shipping shares jumped 10% on Monday after Mango Shipping showed a 46.7% ownership stake in the company. Hexindai Inc. (NASDAQ: HX) shares fell 11.9% to $2.30 in pre-market trading after surging more than 57% on Monday. Borqs Technologies, Inc. (NASDAQ: BRQS) fell 9.4% to $1.15 in pre-market trading after rising around 8% on Monday. Borqs recently filed annual report for year ended December 31, 2019 and regained compliance with Nasdaq continuous listing rules. MorphoSys AG (NASDAQ: MOR) fell 9.3% to $27.52 in pre-market trading as the company reported an offering of approximately EUR 325 million convertible bonds. Iconix Brand Group, Inc. (NASDAQ: ICON) fell 8.7% to $0.94 in pre-market trading after surging around 42% on Monday. Outlook Therapeutics, Inc. (NASDAQ: OTLK) shares fell 8.6% to $0.80 in pre-market trading after climbing around 16% on Monday. Outlook Therapeutics recently highlighted progress on ONS-5010 program. Sunworks, Inc. (NASDAQ: SUNW) fell 7.7% to $2.95 in pre-market trading. Sunworks, disclosed on Oct 7, that Steven Chan has notified the company that he will resign from his position as interim CEO, effective October 22. U.S. Well Services, Inc. (NASDAQ: USWS) fell 7.3% to $0.38 in pre-market trading after declining 6% on Monday. Acorda Therapeutics, Inc. (NASDAQ: ACOR) fell 7.2% to $0.6560 in pre-market trading after declining 4% on Monday. Oxbridge Re Holdings Limited (NASDAQ: OXBR) fell 6.6% to $1.98 in pre-market trading after declining over 10% on Monday. Ocean Power Technologies, Inc. (NASDAQ: OPTT) fell 6% to $2.06 in pre-market trading after dropping 14% on Monday. Ocean Power Technologies, last month, announced a deal with Aspire Capital to sell up to $12.5 million of common stock. Orbital Energy Group, Inc. (NASDAQ: OEG) shares fell 5.6% to $0.7811 in pre-market trading after dropping 8% on Monday. Beyond Meat, Inc. (NASDAQ: BYND) fell 4.2% to $184.25 in pre-market trading after Bernstein downgraded the company’s stock from Market Perform to Underperform and announced a $136 price target.
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.